Your browser doesn't support javascript.
loading
The Risk of Cardiovascular Disease in Prostate Cancer Patients Receiving Androgen Deprivation Therapies.
Cardwell, Chris R; O'Sullivan, Joe M; Jain, Suneil; Harbinson, Mark T; Cook, Michael B; Hicks, Blánaid M; McMenamin, Úna C.
Affiliation
  • Cardwell CR; From the Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
  • O'Sullivan JM; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
  • Jain S; Radiotherapy Department, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland, United Kingdom.
  • Harbinson MT; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
  • Cook MB; Radiotherapy Department, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland, United Kingdom.
  • Hicks BM; Centre for Experimental Medicine, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
  • McMenamin ÚC; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
Epidemiology ; 31(3): 432-440, 2020 05.
Article in En | MEDLINE | ID: mdl-31651660
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Cardiovascular Diseases / Androgen Antagonists Type of study: Etiology_studies / Risk_factors_studies Limits: Humans / Male Language: En Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Cardiovascular Diseases / Androgen Antagonists Type of study: Etiology_studies / Risk_factors_studies Limits: Humans / Male Language: En Year: 2020 Type: Article